Brain aging is the most important risk factor for neurodegenerative disorders, and abnormal apoptosis is linked to neuronal dysfunction. Specifically, studies have found that exercise effectively inhibits hippocampal neuronal apoptosis, while the molecular mechanism remains unclear. In the present study, we investigated the impact of aerobic exercise on hippocampal neuronal apoptosis in aging mice and the potential involvement of DAPK1 and its downstream pathways based on recent data that DAPK1 may be associated with neuronal death in neurodegenerative diseases. Senescent mice were subjected to 8 weeks of Aerobic training. Following behavioral testing, hippocampal samples were examined histologically and biochemically to detect pathological changes, neuronal apoptosis, and mRNA and protein levels. We found that the exercise intervention improved spatial memory and alleviated neuronal apoptosis in the brain. Notably, exercise down‐regulated DAPK1 expression and inhibited Fas death receptor transactivation and the mitochondrial apoptotic pathway in the hippocampus. These results shed new light on the protective effect of regular exercise against brain aging though modulating the DAPK1 pathway.
Therapeutic stagnation in Alzheimer’s disease (AD) highlights the role of non-genetic mechanisms like metabolic dysregulation. We propose a paradigm: exercise reprograms phosphoglycerate dehydrogenase (PHGDH) from a pathogenic nuclear transcription factor to a protective cytoplasmic metabolic enzyme through brain-periphery crosstalk. Under AD-associated stress, PHGDH translocate to the nucleus, where its helix-turn-helix (HHTH) domain activates pro-inflammatory genes (e.g., IKKα, HMGB1), suppresses autophagy, and accelerates Aβ deposition. Centrally, exercise-induced myokine irisin suppresses PHGDH nuclear translocation via AMPK/PGC-1α signaling, preserving its metabolic role. Peripherally, exercise inhibits PHGDH in hepatic Kupffer cells, reducing systemic IL-1β release and neuroinflammation. Notably, the HHTH-targeting inhibitor NCT-503 reduces Aβ plaques by 44–62% in APP-KI mice, validating this strategy. This framework positions exercise as a precision intervention, enabling novel diagnostics (e.g., PET probes for PHGDH compartmentalization) and synergistic “exercise-pharmacotherapy.”